1. Home
  2. AZTR vs RETO Comparison

AZTR vs RETO Comparison

Compare AZTR & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.20

Market Cap

2.2M

Sector

Health Care

ML Signal

HOLD

RETO

ReTo Eco-Solutions Inc.

HOLD

Current Price

$1.09

Market Cap

2.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTR
RETO
Founded
2014
1999
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Multi-Sector Companies
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.5M
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
AZTR
RETO
Price
$0.20
$1.09
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
1.8M
323.3K
Earning Date
02-20-2026
10-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,109,956.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16864.81
52 Week Low
$0.19
$0.83
52 Week High
$2.97
$61.50

Technical Indicators

Market Signals
Indicator
AZTR
RETO
Relative Strength Index (RSI) 27.99 34.22
Support Level $0.19 $0.88
Resistance Level $0.22 $1.45
Average True Range (ATR) 0.02 0.13
MACD -0.00 0.03
Stochastic Oscillator 2.99 13.98

Price Performance

Historical Comparison
AZTR
RETO

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation, and construction of urban ecological environments for capturing, controlling, and reusing rainwater. It operates through two segments, namely Machinery and Equipment sales, and Technology Consulting and other services. The company earns its revenue from the Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: